Tryptase inhibitors

US6962941B2 · kind B2 · utility

Assignee

• ALTANA PHARMA AG · DE

Inventors

• Thomas Martin · Konstanz, DE
• Wolf-Rudiger Ulrich · Konstanz, DE

Key dates

• Filing date: Jun 14, 2002
• Grant date: Nov 8, 2005
• Expiry date: Jun 14, 2022

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The compounds of formula I in which M, B1, B2, R1, R2, R6, R7, K1 and K2 have the meanings as indicated in the description are novel active tryptase inhibitors.